|
1
|
Boyle P and Levin B: World cancer report
2008. International Agency for Research on Cancer; Lyon: World
Health Organization; Geneva: 2008
|
|
2
|
Berruti A, Dogliotti L, Bitossi R, et al:
Incidence of skeletal complications in patients with bone
metastatic prostate cancer and hormone refractory disease:
predictive role of bone resorption and formation markers evaluated
at baseline. J Urol. 64:1248–1253. 2000. View Article : Google Scholar
|
|
3
|
Meuser T, Pietruck C, Radbruch L, Stute P,
Lehmann KA and Grond S: Symptoms during cancer pain treatment
following WHO-guidelines: a longitudinal follow-up study of symptom
prevalence, severity and etiology. Pain. 93:247–257. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van den Beuken-van Everdingen MH, de Rijke
JM, Kessels AG, et al: Prevalence of pain in patients with cancer:
a systematic review of the past 40 years. Ann Oncol. 18:1437–1449.
2007.PubMed/NCBI
|
|
5
|
Weichselbaum RR and Hellman S:
Oligometastases revisited. Nat Rev Clin Oncol. 8:378–382. 2011.
|
|
6
|
Ollila DW, Gleisner AL and Hsueh EC:
Rationale for complete metastasectomy in patients with stage IV
metastatic melanoma. J Surg Oncol. 104:420–424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh D, Yi WS, Brasacchio RA, et al: Is
there a favorable subset of patients with prostate cancer who
develop oligometastases? Int J Radiat Oncol Biol Phys. 58:3–10.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coleman R: Management of bone metastases.
Cancer Treat Rev. 23(Suppl 1): S69–S75. 1997. View Article : Google Scholar
|
|
9
|
Lipton A: Implications of bone metastases
and the benefits of bone-targeted therapy. Semin Oncol. 37(Suppl
2): S15–S29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rose AA and Siegel PM: Emerging
therapeutic targets in breast cancer bone metastasis. Future Oncol.
6:55–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McMenomy BP, Kurup AN, Johnson GB, et al:
Percutaneous cryoablation of musculoskeletal oligometastatic
disease for complete remission. J Vasc Interv Radiol. 24:207–213.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Callstrom MR and Kurup AN: Percutaneous
ablation for bone and soft tissue metastases - why cryoablation?
Skeletal Radiol. 38:835–839. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brace CL: Radiofrequency and microwave
ablation of the liver, lung, kidney, and bone: what are the
differences? Curr Probl Diagn Radiol. 38:135–143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ford J, Cummins E, Sharma P, et al:
Systematic review of the clinical effectiveness and cost
effectiveness and economic evaluation of denosumab for the
treatment of bone metastases from solid tumors. Health Technol
Assess. 17:1–386. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Coleman RE: Skeletal complications of
malignancy. Cancer. 80(8 Suppl): 1588–1594. 1997. View Article : Google Scholar
|
|
16
|
Delea T, Langer C, McKiernan J, et al: The
cost of treatment of skeletal-related events in patients with bone
metastases from lung cancer. Oncology. 67:390–396. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
National Cancer Institute and National
Institutes of Health. Common Terminology Criteria for Adverse
Events (CTCAE), Version 4.0. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdfuri.
Accessed February 10, 2009
|
|
18
|
Ripamonti CI and Brunelli C: Comparison
between numerical rating scale and six-level verbal rating scale in
cancer patients with pain: a preliminary report. Support Care
Cancer. 17:1433–1434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tian J, Chen ZC and Hang LF: Effects of
nutritional and psychological status of the patients with advanced
stomach cancer on physical performance status. Support Care Cancer.
17:1263–1268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marks RM and Sachar EJ: Undertreatment of
medical inpatients with narcotic analgesics. Ann Intern Med.
78:173–181. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peteet J, Tay V, Cohen G and MacIntyre J:
Pain characteristics and treatment in an outpatient cancer
population. Cancer. 57:1259–1265. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Portenoy RK, Miransky J, Thaler HT, et al:
Pain in ambulatory patients with lung or colon cancer. Prevalence,
characteristics, and effect. Cancer. 70:1616–1624. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Amadori D, Aglietta M, Alessi B, et al:
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid
for prolonged treatment of patients with bone metastases from
breast cancer (ZOOM): a phase 3, open-label, randomised,
non-inferiority trial. Lancet Oncol. 14:663–670. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rosen LS, Gordon D, Tchekmedyian S, et al:
Zoledronic acid versus placebo in the treatment of skeletal
metastases in patients with lung cancer and other solid tumors: a
phase III, double-blind, randomized trial - The Zoledronic Acid
Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol.
21:3150–3157. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saad F: Clinical benefit of zoledronic
acid for the prevention of skeletal complications in advanced
prostate cancer. Clin Prostate Cancer. 4:31–37. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choi J and Raghavan M: Diagnostic imaging
and image-guided therapy of skeletal metastases. Cancer Control.
19:102–112. 2012.
|
|
27
|
Hatoum HT, Lin SJ, Smith MR, Barghout V
and Lipton A: Zoledronic acid and skeletal complications in
patients with solid tumors and bone metastases: analysis of a
national medical claims database. Cancer. 113:1438–1445. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Beland MD, Dupuy DE and Mayo-Smith WW:
Percutaneous cryoablation of symptomatic extraabdominal metastatic
disease: preliminary results. AJR Am J Roentgenol. 184:926–930.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Callstrom MR, Atwell TD, Charboneau JW, et
al: Painful metastases involving bone: percutaneous image-guided
cryoablation - prospective trial interim analysis. Radiology.
241:572–580. 2006. View Article : Google Scholar : PubMed/NCBI
|
